Yalin Tu

A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma

Weiqin Yang, Yu Feng, Jingying Zhou et al. · Science Translational Medicine · 2021 · 162 citations

Medicine, Oncology, Pharmacology +16

Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway

Jingkao Chen, Zhaowei Sun, Minghua Jin et al. · Journal of Neuroimmunology · 2017 · 137 citations

Life Sciences, Immunology, Neuroscience +17

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma

Zhewen Xiong, Stephen L. Chan, Jingying Zhou et al. · Gut · 2023 · 100 citations · Full text

Life Sciences, Immunology, Oncology +17

Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma

Yalin Tu, Yameng Sun, Shuang Qiao et al. · Journal of Medicinal Chemistry · 2021 · 93 citations

Medicine, Oncology, Pharmacology +15

Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease

Ziwei Chen, Maria Digiacomo, Yalin Tu et al. · European Journal of Medicinal Chemistry · 2016 · 71 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14